Olympus (7733) Stock Price, Fundamentals & Analysis
Price
2,024 JPY
+1.45%
Last trade: Sep 25, 2026, 03:30 PM GMT+9
Updated: Sep 27, 2026, 06:39 PM GMT+9
Price history
Over the past year 7733 traded between 1,310.5 JPY and 2,187 JPY, closing at 2,024 JPY on Sep 25, 2026.
Key statistics
| Market cap | 2.15T JPY |
|---|---|
| P/E ratio (TTM) | 33.1 |
| Forward P/E | 16.1 |
| EPS (TTM) | 61.12 JPY |
| Dividend yield | 1.48% |
| Annual dividend | 30 JPY |
| Ex-dividend date | Mar 30, 2027 |
| Payout ratio | 49% |
| 52-week range | 1,302.5 – 2,210.5 |
| 52-week change | 9.4% |
| Beta | 0.22 |
| Price / book | 2.88 |
| Revenue (TTM) | 1.04T JPY |
| Revenue growth (YoY) | 16.4% |
| Gross margin | 64.7% |
| Operating margin | 12.5% |
| Profit margin | 7.5% |
| Return on equity | 10.6% |
| Debt / equity | 42.6 |
| Volume | 3,524,800 |
| Average volume | 4,419,848 |
| Next earnings | Nov 10, 2026 |
| Exchange | Tokyo |
Profile
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 28,138
- Headquarters
- Hachioji, Japan
- Website
- olympus.co.jp
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003.
Overview
What 7733 does
Olympus (7733) is a stock listed on the Tokyo Stock Exchange stocks. It operates in the Healthcare sector, specifically the Medical Devices industry, and is headquartered in Hachioji, Japan. The company designs and sells medical equipment across Japan, America, the Middle East, Asia, and Oceania. Olympus operates through two segments: Gastrointestinal Solutions, which includes endoscopes and gastroenterology devices, and Surgical & Interventional Solutions, which covers urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. With 28,138 employees, it is a large-cap component of the Japanese market and a peer to companies like Takeda Pharmaceutical (4502) and Daiichi Sankyō (4568).
Key numbers explained
- The current price is 2,024 JPY, up +1.45% today.
- The trailing P/E ratio of 33.1 shows how much investors pay per unit of recent earnings; a higher figure often reflects growth expectations.
- The forward P/E ratio of 16.1 uses expected future earnings and can look more attractive if growth is anticipated.
- The dividend yield of 1.48% indicates the annual dividend as a percentage of the current price; the ex-dividend date is Mar 30, 2027.
- 49% of earnings are paid out as dividends, meaning the company retains the rest for reinvestment.
- The beta of 0.22 suggests the stock tends to move less than the overall market, which can mean lower volatility.
- The 52-week range of 1,302.5 – 2,210.5 shows the lowest and highest traded prices over the past year, with the current price near the upper end.
- The price change over the last 52 weeks of 9.4% measures total return from one year ago to today.
What to watch
Olympus operates in a regulated industry where product approvals, reimbursement policies, and innovation cycles can affect demand. As a large-cap Healthcare stock, it is sensitive to currency movements, especially the Japanese yen, and to global healthcare spending trends. Investors often compare it with peers such as M3, Inc. (2413) and Chugai Pharmaceutical (4151) to gauge sector positioning. The next earnings report, scheduled for Nov 10, 2026, can provide updates on revenue growth, margins, and outlook.
Latest news & filings
No recent headlines.
Frequently asked questions
Does 7733 pay a dividend?
Yes. Olympus pays a dividend with a yield of 1.48%, and the ex-dividend date is Mar 30, 2027.
What is the 7733 P/E ratio?
The trailing P/E ratio is 33.1, while the forward P/E ratio based on expected earnings is 16.1.
Where can I buy 7733?
Olympus (7733) trades on the Tokyo Stock Exchange. You can buy it through any broker that offers access to Japanese equities.
What sector and industry is 7733 in?
It is in the Healthcare sector and the Medical Devices industry.
How volatile is 7733 compared to the market?
Its beta is 0.22, indicating it tends to be less volatile than the broader market.
What was 7733's price change over the last year?
The price changed by 9.4% over the last 52 weeks.
Related
More on 7733
Track 7733 in your portfolio
Hold 7733 at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free